Current medical science

Using Lipid-Based Drugs to Target Aging Fat Cells for Treating Metabolic Diseases

Updated

Abstract

Adipose tissue dysfunction is closely linked to aging and the development of multiple diseases.

  • Adipose tissue serves as both an energy reservoir and an endocrine organ.
  • Key characteristics of adipocyte senescence contribute to obesity, type 2 diabetes, and cardiovascular diseases.
  • Current intervention strategies for adipocyte senescence include senolytics, senomorphics, caloric restriction, physical exercise, and gene editing.
  • Lipid prodrugs may enhance drug delivery to adipose tissue, potentially increasing local drug concentration and reducing systemic toxicity.
  • Exploiting the unique lipid metabolism of adipocytes could provide new therapeutic options for addressing metabolic disorders.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free